Dalfampridine-ER

dalfampridine · Acorda Therapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Dalfampridine-ER, covering 2012-11-07 to 2017-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis [Phase 3]